Regulation of NF-κB2/p100 processing by its nuclear shuttling

Oncogene

Volumn 22, Issue 31, 2003, Pages 4868-4874

  Liao, Gongxian ^a   Sun, Shao Cong ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Leptomycin B; NF B; Nuclear localization signal; p100; Protein processing

Indexed keywords

ANKYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PRECURSOR PROTEIN P100; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; HYBRID PROTEIN; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL NUCLEUS; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS;

ANIMALIA;

ANIMALS; ANKYRIN REPEAT; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0042736200     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206761     Document Type: Article

References (37)

1. Baldwin Jr AS. (1996). Annu. Rev. Immunol, 14, 649-683.
2. Barkett M and Gilmore TD. (1999). Oncogene, 69, 6910-6924.
3. Belich MP, Salmeron A, Johnston LH and Ley SC. (1999). Nature, 397, 363-368.
4. Blondel M, Galan JM, Chi Y, Lafourcade C, Longaretti C, Deshaies RJ and Peter M. (2001). EMBO J., 19, 6085-6097.
5. Claudio E, Brown K, Park S, Wang H and Siebenlist U. (2002). Nat. Immunol., 3, 958-965.
6. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH and Ley SC. (2002). EMBO J., 15, 5375-5385.
7. Davis M, Hatzubai A, Andersen JS, Ben-Shushan E, Fisher GZ, Yaron A, Bauskin A, Mercurio F, Mann M and BenNeriah Y. (2002). Genes Dev., 16, 439-451.
8. Dejardin, E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF and Green DR. (2002). Immunity, 17, 525-535.
9. Fan CM and Maniatis T. (1991). Nature, 354, 395-398.
10. Feinstein E, Kimchi A, Wallach D, Boldin M and Varfolomeev E. (1995). Trends Biochem. Sci., 20, 342-344.
11. Fong A and Sun S-C. (2002). J. Biol. Chem, 277, 22111-22114.
12. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M and Nishida E. (1997). Nature. 390, 308-311.
13. Ganchi PA, Sun S-C, Greene WC and Ballard DW. (1992). Mol. Biol. Cell, 3, 1339-1352.
14. Harhaj EW, Maggirwar SB and Sun S-C. (1996). Oncogene, 12, 2385-2392.
15. Harhaj EW and Sun S-C. (1999). Mol. Cell. Biol., 19, 7088-7095.
16. Heissmeyer V, Krappmann D, Wulczyn FG and Scheidereit C. (1999). EMBO J., 18, 4766-4778.
17. Ishikawa H, Carrasco D, Claudio E, Ryseck RP and Bravo R. (1997). J. Exp. Med., 186, 999-1014.
18. Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C and Bravo R. (1998). J. Exp. Med., 187, 985-996.
19. Karin M and Ben-Neriah Y. (2000). Annu. Rev. Immunol, 18, 621-663.
20. Karin M and Lin A. (2002). Nat. Immunol., 3, 221-227.
21. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA and Dixit VM. (2002). Immunity, 17, 515-524.
22. Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R and Margottin-Goguet F. (2001). Mol. Cell. Biol., 21, 2192-2202.
23. Mercurio F, DiDonato JA, Rosette C and Karin M. (1993). Genes Dev., 7, 705-718.
24. Neri A, Fracchiolla NS, Migliazza A, Trecca D and Lombardi L. (1996). Leuk. Lymphoma, 23, 43-48.
25. Orian A, Gonen H, Bercovich B, Fajerman I, Eytan E, Israel A, Mercurio F, Iwai K, Schwartz AL and Ciechanover A. (2000). EMBO J., 19, 2580-2591.
26. Rayet B and Gelinas C. (1999). Oncogene, 18, 6938-6947.
27. Rice NR, MacKichan ML and Israel A. (1992). Cell, 71, 243-253.
28. Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B and Ben-Ze'ev A. (2001). Oncogene, 19, 1992-2001.
29. Senftleben U, Cao Y, Xiao G, Kraehn G, Greten F, Chen Y, Hu Y, Fong A, Sun S-C and Karin M. (2001). Science, 293, 1495-1499.
30. Siebenlist U, Franzoso G and Brown K. (1994). Annu. Rev. Cell Biol., 10, 405-455.
31. Silverman N and Maniatis T. (2001). Genes Dev., 15, 2321-2342.
32. Solan NJ, Miyoshi H, Carmona EM, Bren GD and Paya CV. (2002). J. Biol. Chem., 277, 1405-1418.
33. Sun S-C, Ganchi PA, Beraud C, Ballard DW and Greene WC. (1994). Proc. Natl. Acad. Sci. USA, 91, 1346-1350.
34. Waterfield MR, Zhang M, Norman LP and Sun SC. (2003). Mol. Cell, 11, 685-694.
35. Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M and Sun SC. (2001a). EMBO J., 20, 6805-6815.
36. Xiao G, Harhaj EW and Sun SC. (2001b). Mol. Cell, 7, 401-409.
37. Yu ZK, Geyer RK and Maki CG. (2000). Oncogene, 19, 5892-5897.